Keyphrases
ACE Inhibitor Therapy
31%
Acute Coronary Syndrome
94%
Acute Heart Failure
31%
Acute Myocardial Infarction
100%
Arterial Thrombosis
31%
Asymmetric Dimethylarginine
31%
Cardiology
31%
Cardiovascular Risk
31%
Cardiovascular System
31%
Carotid Intima-media Thickness (cIMT)
53%
CD40 Ligand (CD40L)
31%
Coastal Defence
31%
Coastal Defense System
31%
Do-it-yourself
31%
East Java Indonesia
31%
Echocardiography
31%
Economic Impact
31%
Exposure to Air Pollution
31%
Female Migration
31%
General Hospital
43%
Global Longitudinal Strain
62%
Heart Failure Patients
31%
High On-treatment Platelet Reactivity
31%
Indonesia
35%
Left Ventricular Remodeling
66%
Left-behind Parents
31%
Leukocytosis
31%
Light Transmission
31%
Low-dose Effects
31%
Myocardial Infarction Patients
47%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
31%
Nine-level
31%
Party Development
31%
Platelet Aggregometry
31%
Platelet Response
31%
Polycythemia Vera
31%
Post-myocardial Infarction
31%
Post-percutaneous Coronary Intervention
31%
Social Impact
31%
Soluble Suppression of Tumorigenicity 2 (sST2)
62%
Soot Particulates
31%
ST-elevation Myocardial Infarction (STEMI)
74%
Surabaya
43%
System Disruption
31%
Ticagrelor
31%
Troponin
35%
Two-dimensional Speckle Tracking Echocardiography
31%
Vascular Cell Adhesion molecule-1 (VCAM-1)
31%
Venous Thrombosis
31%
Wall Motion Score Index
31%
Pharmacology, Toxicology and Pharmaceutical Science
6 N,n' Dimethylarginine
31%
Acute Coronary Syndrome
62%
Acute Heart Failure
31%
Acute Heart Infarction
73%
Atherosclerosis
16%
Biological Marker
15%
Cardiovascular Risk
31%
CD40 Ligand
31%
Congestive Heart Failure
6%
Cross-Sectional Study
8%
Dipeptidyl Carboxypeptidase Inhibitor
31%
End Stage Renal Disease
31%
Enzyme-Linked Immunosorbent Assay
11%
Galectin 3
31%
Gelatinase B
31%
Heart Disease
13%
Heart Infarction
39%
Heart Muscle Fibrosis
8%
Heart Ventricle Remodeling
13%
Hemodialysis
22%
Homocysteine
13%
Immunoassay
8%
Inflammation
11%
Ischemia
8%
Myeloperoxidase
27%
N(g),n(g) Dimethylarginine
31%
Non ST Segment Elevation Myocardial Infarction
18%
Observational Study
13%
ST Segment Elevation Myocardial Infarction
37%
Thorax Pain
16%
Treatment Group
7%
Unstable Angina Pectoris
10%
Vascular Cell Adhesion Molecule 1
31%